Zyon Ayni: “I Trained for Years for this Battle”
January 31, 2022
Zyon Ayni, CEO and founder of Code Pharma, had an interview for an Israeli TV channel (14) following his winning the Thai Boxing Championship Belt
Press
Read More »
Chief Scientific Officer at Code Pharma on ynet
January 16, 2022
Chief Scientific Officer at Code Pharma, Dr. Eynat Finkelshtein, appeared on ynet TV and talked about Codivir: “When the Covid-19 showed up, we decided to
Zyon Ayni on IssueWire: “We Are at a Critical Stage”
December 12, 2021
Codivir, a COVID-19 and RNA virus antiviral medication, is being developed by Code Pharma, a Dutch pharmaceutical company. Through the utilization of new peptides, the
Yahoo Finance: “Code Pharma Announces Plans for IPO”
November 30, 2021
Yahoo Finance published an article about Code Pharma: “The company today announced its intention to launch an Initial Public Offering (IPO) and list its shares
Codivir and Code Pharma on TradeArabia
November 25, 2021
Codivir and Code Pharma were some of the topics discussed in an article on Trade Arabia. Code Pharma Founder and CEO Zyon Ayni quoted: “We
Zyon Ayni: “I Have Never Given Up” | Pressat
October 28, 2021
After being confirmed to be effective against the COVID-19, the antiviral medicine Codivir from Code Pharma has got emergency authorization for usage in several countries.
Zyon Ayni on Global Trend Monitor: “The Medication Is Proven To Be Safe”
October 5, 2021
Codivir, a medication that gets COVID-19 affected patients up and about in 48 hours with no side effects, is being developed by Code Pharma. Zyon
“New Antiviral Drug Has the Potential to Stop COVID-19” | The Jerusalem Post
September 15, 2021
Codivir, a drug used to treat HIV with a direct antiviral effect on coronavirus, was featured in an article in the Jerusalem Post. The goal,
Zyon Ayni: The Effect of Codivir on Covid-19 | AP News
September 5, 2021
Antiviral drug Codivir, developed by Code Pharma BV, shows promising effect against COVID-19, wrote AP News. Codivir, a short synthetic 16 amino-acid peptide derived from